| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $158.7M | -11.5% |
| SG&A Expense | $49.1M | +4.4% |
| Operating Income | -$212.8M | +14.2% |
| Income Tax | $0 | — |
| Net Income | -$198.6M | +17.7% |
| EPS (Basic) | -$1.81 | +18.8% |
| EPS (Diluted) | -$1.81 | +18.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $200.6M | +117.9% |
| Current Assets | $224.9M | -40.3% |
| Total Assets | $229.2M | -40.2% |
| Current Liabilities | $50.3M | +100.9% |
| Total Liabilities | $51.7M | +90.1% |
| Stockholders' Equity | $177.5M | -50.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$173.2M | +21.3% |
| Capital Expenditures | $615K | -63.9% |
| Investing Cash Flow | $280.7M | +221.7% |
| Financing Cash Flow | $1.0M | +106.5% |
| Free Cash Flow | -$173.8M | +21.6% |